{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:25:28Z","timestamp":1778657128815,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.02.047","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T16:10:30Z","timestamp":1362499830000},"page":"2145-2151","source":"Crossref","is-referenced-by-count":23,"title":["A systematic review of rubella vaccination strategies implemented in the Americas: impact on the incidence and seroprevalence rates of rubella and congenital rubella syndrome"],"prefix":"10.1016","volume":"31","author":[{"given":"Norma","family":"Mongua-Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"D\u00edaz-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maricela","family":"Pi\u00f1a-Pozas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Ferreira-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Delgado-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Ferreyra-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Pablo","family":"Cruz-Hervert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Baez-Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio","family":"Campos-Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.02.047_bib0005","unstructured":"Organizaci\u00f3n Panamericana de la salud. Expertos en vacunaci\u00f3n dan recomendaciones para mantener los logros en inmunizaci\u00f3n y asegurar acceso en la regi\u00f3n a nuevas vacunas. OPS: Bolet\u00edn Informativo 2011; 26. [Accessed February 2012] Available from: http:\/\/www.ops.org.bo\/imagenes\/Boletines%20OPS\/bOLETIN_EXPERTOS_pai_nUEVAS_VACUNAS.pdf."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0010","unstructured":"Pan American Health Organization. Reported coverage in the Americas by vaccine. Washington, DC.: PAHO; 2010. [Accessed September 2011] Available from: http:\/\/ais.paho.org\/phip\/viz\/im_coveragebyvaccine.asp."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0015","unstructured":"Pan American Health Organization. Immunization technical information data and statistics morbidity. Washington, DC.: PAHO.;1; 2010. [Accessed September 2011] Available from: http:\/\/ais.paho.org\/phip\/viz\/im_vaccinepreventablediseases.asp."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0020","unstructured":"World Health Organization. Rubella vaccines: WHO position paper. Weekly epidemiological record 2011; 86 (29): 301-316."},{"issue":"8314\u20135","key":"10.1016\/j.vaccine.2013.02.047_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(83)91572-6","article-title":"Rational strategy for rubella vaccination","volume":"1","author":"Hinman","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.047_bib0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00006454-198501000-00006","article-title":"Elimination of rubella and congenital rubella from the United States","volume":"4","author":"Bart","year":"1985","journal-title":"Pediatric Infectious Disease."},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.047_bib0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jama.1996.03530270064033","article-title":"Measles elimination in the Americas. Evolving strategies","volume":"275","author":"De Quadros","year":"1996","journal-title":"JAMA."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0040","unstructured":"World Health Organization. Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs. Geneva 27, Switzerland. 2000: 52-53. [Accessed April 2011] Available from: http:\/\/www.who.int\/vaccines-documents\/DocsPDF00\/www508.pdf."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0045","unstructured":"Pan American Health. Plan de Acci\u00f3n para la documentaci\u00f3n y verificaci\u00f3n de la eliminaci\u00f3n de sarampi\u00f3n, rub\u00e9ola y s\u00edndrome de rub\u00e9ola cong\u00e9nita en la Regi\u00f3n de las Am\u00e9ricas. Washington, D.C: PAHO; 2009."},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.047_bib0050","first-page":"337","article-title":"[Incidence and transmission patterns of rubella in Mexico]","volume":"49","author":"D\u00edaz-Ortega","year":"2007","journal-title":"Salud P\u00fablica De M\u00e9xico."},{"issue":"20","key":"10.1016\/j.vaccine.2013.02.047_bib0055","first-page":"2201","article-title":"Rubella immunization","volume":"235","author":"Herrmann","year":"1976","journal-title":"Persistence of antibody four years after a large-scale field trial. JAMA: The Journal of the American Medical Association."},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.047_bib0060","first-page":"415","article-title":"Impact of rubella vaccination strategy on the occurrence of congenital rubella syndrome","volume":"83","author":"Lanzieri","year":"2007","journal-title":"Journal De Pediatria."},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.047_bib0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1590\/S1020-49892011000400005","article-title":"Outbreak of rubella after mass vaccination of children and adult women: challenges for rubella elimination strategies","volume":"29","author":"Menegolla","year":"2011","journal-title":"Revista panamericana de salud publica = Pan American journal of public health."},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.047_bib0070","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ije\/24.4.842","article-title":"Assessing the efficacy of a mixed vaccination strategy against rubella in S\u00e3o Paulo","volume":"24","author":"Massad","year":"1995","journal-title":"Brazil. International Journal of Epidemiology."},{"issue":"214","key":"10.1016\/j.vaccine.2013.02.047_bib0075","first-page":"205","article-title":"Evaluation of the immunization impact on the epidemiology of rubella and congenital rubella syndrome in Argentina","volume":"47","author":"Man","year":"2005","journal-title":"Rev. Hosp. Ni\u00f1os B. Aires"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.047_bib0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/oxfordjournals.aje.a114387","article-title":"Prevalence of rubella antibodies in Massachusetts schoolchildren","volume":"124","author":"Orenstein","year":"1986","journal-title":"American Journal of Epidemiology."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0085","unstructured":"Instituto Nacional de Estad\u00edsticas y Censos INDEC. Censo Nacional de Poblaci\u00f3n, hogares y viviendas, Argentina. 1991 y 2001. [Accessed September 2012] Available in http:\/\/www.indec.mecon.ar\/principal.asp?id_tema=50."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0090","unstructured":"Science Data Analysis Network SSDAN. Massachusetts census 1960-2000. [Accessed September 2012] Available in http:\/\/www.censusscope.org\/us\/s25\/chart_popl.html."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0095","unstructured":"Direcci\u00f3n General de Epidemiologia. Anuarios de morbilidad 1984-2010. Poblaci\u00f3n por grupo de edad y entidad federativa, Estados Unidos Mexicanos, 2011. [Accessed September 2012] Available in: http:\/\/www.dgepi.salud.gob.mx\/anuario\/html\/anuarios.html."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0100","unstructured":"Fundaci\u00f3n Sistema Estatal de An\u00e1lisis de datos SEADE. Estadisticas vitales. [Accessed September 2012] Available in http:\/\/www.seade.gov.br\/produtos\/500anos\/consulta.php."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0105","unstructured":"Red Interagencial de Informaci\u00f3n para la Salud RIPSA. Indicadores demogr\u00e1ficos. [Accessed September de 2012] Available in http:\/\/tabnet.datasus.gov.br\/cgi\/tabcgi.exe?idb2010\/a01.def."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0110","unstructured":"Pan American Health Organization. Number of vaccine preventable disease (VDP) cases in the Americas. 1996-2010. [Accessed September 2012] Available in http:\/\/ais.paho.org\/phip\/viz\/im_vaccinepreventablediseases.asp."},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.047_bib0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1745-6215-11-32","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"11","author":"Schulz","year":"2010","journal-title":"Trials."},{"key":"10.1016\/j.vaccine.2013.02.047_bib0120","unstructured":"Wells GA, Shea B. O\u2019Connel D, Peterson J. Welch V, Losios M. Tugwell, P.;1; The Newcastle- Ottawa Scale (NOS) for assesing the quality of nonrandomised studies in metanalyses. Ottawa, Ca: OHRI; 2011. [Accessed April 2011] Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/nosgen.pdf."},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.047_bib0125","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1157\/13126932","article-title":"Instrumento para la lectura cr\u00edtica y la evaluaci\u00f3n de los estudios epidemiol\u00f3gicos transversales","volume":"22","author":"Berra","year":"2008","journal-title":"Gac Sanit."},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.047_bib0130","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/605410","article-title":"Persistence of Rubella Antibodies after 2 Doses of Measles-Mumps-Rubella Vaccine","volume":"200","author":"LeBaron Charles","year":"2009","journal-title":"The Journal of Infectious Diseases."},{"issue":"7","key":"10.1016\/j.vaccine.2013.02.047_bib0135","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2105\/AJPH.72.7.710","article-title":"Rubella susceptibility in inner-city adolescents: the effect of a school immunization law","volume":"72","author":"Nelson","year":"1982","journal-title":"American Journal of Public Health."},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.047_bib0140","first-page":"192","article-title":"Presencia de anticuerpos a sarampi\u00f3n, rub\u00e9ola y parotiditis en una poblaci\u00f3n cubana de 7 meses a 23 a\u00f1os","volume":"56","author":"Ribas","year":"2004","journal-title":"Rev Cubana Med Trop"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2013.02.047_bib0145","first-page":"3795","article-title":"Seroprevalence of rubella antibodies in the State of S\u00e3o Paulo","volume":"21","author":"Zanetta","year":"2003","journal-title":"Brazil, 8 years after the introduction of vaccine. Vaccine."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2013.02.047_bib0150","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1086\/368034","article-title":"New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas","volume":"187","author":"Castillo-Sol\u00f3rzano","year":"2003","journal-title":"The Journal of Infectious Diseases."},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.047_bib0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/oxfordjournals.aje.a115138","article-title":"Congenital rubella syndrome in the United States, 1970-1985","volume":"129","author":"Cochi","year":"1989","journal-title":"On the verge of elimination. American Journal of Epidemiology."},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.047_bib0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.inf.0000260000.84792.9e","article-title":"Estimating the burden of congenital rubella syndrome in Costa Rica, 1996-2001","volume":"26","author":"Jim\u00e9nez","year":"2007","journal-title":"The Pediatric infectious disease journal."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2013.02.047_bib0165","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1086\/368053","article-title":"Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience","volume":"187","author":"33 Morice","year":"2003","journal-title":"The Journal of Infectious Diseases."},{"issue":"10","key":"10.1016\/j.vaccine.2013.02.047_bib0170","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2105\/AJPH.90.10.1545","article-title":"Strategies to eradicate rubella in the English-speaking Caribbean","volume":"90","author":"Irons","year":"2000","journal-title":"American Journal of Public Health."},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2013.02.047_bib0175","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1086\/505944","article-title":"The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission","volume":"43","author":"Reef","year":"2006","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America."},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.047_bib0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4038\/cmj.v47i2.3453","article-title":"Strategies for immunisation against rubella: evidence from a study in the Kalutara District","volume":"47","author":"Palihawadana","year":"2002","journal-title":"Ceylon MedJ."},{"issue":"12","key":"10.1016\/j.vaccine.2013.02.047_bib0185","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/01.inf.0000145479.04559.97","article-title":"Incidence, clinical features and estimated costs of congenital rubella syndrome after a large rubella outbreak in Recife, Brazil, 1999-2000","volume":"23","author":"Lanzieri","year":"2004","journal-title":"The Pediatric infectious disease journal."},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.047_bib0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/14760584.8.3.323","article-title":"Congenital rubella syndrome: progress and future challenges","volume":"8","author":"Morice","year":"2009","journal-title":"Expert Review of Vaccines."},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.047_bib0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0025-5564(95)00034-8","article-title":"Simultaneous control of measles and rubella by multidose vaccination schedules","volume":"131","author":"Becker","year":"1996","journal-title":"Mathematical Biosciences."},{"issue":"16","key":"10.1016\/j.vaccine.2013.02.047_bib0200","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.vaccine.2007.01.019","article-title":"Progress in Italy in control and elimination of measles and congenital rubella","volume":"25","author":"Bonanni","year":"2007","journal-title":"Vaccine."},{"issue":"14","key":"10.1016\/j.vaccine.2013.02.047_bib0205","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(97)00068-6","article-title":"Twenty years\u2019 experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination","volume":"15","author":"Bottiger","year":"1997","journal-title":"Vaccine."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2013.02.047_bib0210","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1093\/infdis\/jir082","article-title":"Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts","volume":"204","author":"Zimmerman","year":"2011","journal-title":"J Infect Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.047_bib0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/epirev\/mxf002","article-title":"Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy","volume":"24","author":"Vyse","year":"2002","journal-title":"Epidemiol Rev."},{"issue":"7","key":"10.1016\/j.vaccine.2013.02.047_bib0220","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis."},{"issue":"27","key":"10.1016\/j.vaccine.2013.02.047_bib0225","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/S0264-410X(00)00139-0","article-title":"Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland","volume":"18","author":"Davidkin","year":"2000","journal-title":"Vaccine."},{"issue":"14","key":"10.1016\/j.vaccine.2013.02.047_bib0230","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.vaccine.2005.12.015","article-title":"Waning antibodies in measles and rubella vaccinees--a longitudinal study","volume":"24","author":"Kremer","year":"2006","journal-title":"Vaccine."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:05:35Z","timestamp":1688079935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13002363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":46,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13002363"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}